GADx Awarded Grand Prize for Maternal Health Innovation

Global Access Diagnostics (GADx) is thrilled to announce that we have been awarded the grand cash prize for our at-home urinary tract infection diagnostic by the National Institutes of Health’s (NIH) RADx Tech for Maternal Health Challenge. This prestigious recognition highlights our commitment to improving maternal health outcomes, particularly for postpartum individuals living in maternity care deserts. 

Revolutionising UTI Diagnostics for New Mothers 

Urinary tract infections (UTIs) can significantly impact postpartum women, especially those who have undergone catheterisation during or after delivery. Our rapid home test, UTRiPLEX, aims to address this issue head-on by offering an accessible, accurate, and easy-to-use diagnostic solution. 

Originally designed for healthcare professionals, our innovation was adapted during the RADx Tech challenge to be more user-friendly for at-home testing, much like a traditional pregnancy test. 

Key Features of UTRiPLEX: 

  • Ease of Use: The test has an ergonomic handle and distinct shape outlines around the control and test lines, simplifying use for individuals without medical training. 
  • Quick Results: It provides fast detection of active infections, allowing for prompt treatment and reducing the time spent waiting for diagnosis. 
  • On-Device Results Key: A results key on the device makes interpretation simple, without the need for any additional instructions or materials. 
  • Accuracy: UTRiPLEX is designed to be more precise than current over-the-counter (OTC) solutions, ensuring that mothers can trust the results they receive. 

Upon regulatory approval, UTRiPLEX will be available over the counter, providing mothers the ability to diagnose and treat UTIs early, without the need for in-person GP appointments. 

Please note: UTRiPLEX is a prototype device, and its performance has not yet been fully established or authorised for sale. 

A Mission for Global Health 

Andrew Wheeler, General Manager at GADx, USA, emphasises our broader mission: 

“Maternal health challenges transcend borders—they affect women globally, regardless of geography or economics. With UTRiPLEX, we aim to bring meaningful change, providing accessible diagnostic tools to all, whether they’re in a high-tech hospital or a remote village. Improving maternal health outcomes is at the core of our mission to make quality diagnostics accessible for everyone.” 

Shoutout to Our Incredible Team 

None of this would have been possible without the dedication and hard work of our amazing team members. Their expertise, passion, and unwavering commitment to advancing maternal health have been instrumental in our success. 

Looking Ahead 

We are excited to continue pushing the boundaries of what’s possible in maternal health diagnostics. With the support of the RADx Tech for Maternal Health Challenge, our mission to make quality, accessible healthcare available to mothers everywhere is just beginning. We believe that every mother deserves the peace of mind that comes from knowing her health is in good hands, and we will keep innovating to make that vision a reality. 

  • The GADx Team 

Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.

Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.